Status:
COMPLETED
Ultrasound Measurement of Quadriceps Shortening During Neuromuscular Electrical Stimulation in Critically Ill Patients
Lead Sponsor:
Groupe Hospitalier du Havre
Conditions:
ICU Acquired Weakness
Quadriceps Muscle Atrophy
Eligibility:
All Genders
18+ years
Brief Summary
ICU-Aw is highly prevalent (50%) among critically ill patients. Its diagnosis is usually delayed as it requires patients' awakening and collaboration to provide accurate measurement. This study aims ...
Eligibility Criteria
Inclusion
- Mechanical ventilation for at least 24 hours
Exclusion
- Decision to withhold life-sustaining treatment
- Pregnancy
- Degenerative neurological pathology with disabling muscle weakness
- Pace Maker
- Inability to communicate
- Chronic loss of autonomy described by the patient's family
- Guardianship
Key Trial Info
Start Date :
August 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04722445
Start Date
August 16 2021
End Date
December 30 2023
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier du Havre
Montivilliers, France, 76290